Vera Therapeutics, Inc. (VERA)

NASDAQ: VERA · Real-Time Price · USD

30.09

-0.44 (-1.44%)

At close: Oct 10, 2025, 4:00 PM EDT

29.20

-0.89 (-2.96%)

After-hours: Oct 10, 2025, 6:07 PM EDT

Vera Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct '25 Oct 10, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Cap	1,920	2,688	694	538	569	245
Market Cap Growth	-22.02%	287.37%	28.99%	-5.38%	132.35%	-
Enterprise Value	1,441	2,100	584.45	451.93	493.79	330.61
Last Close Price	30.09	42.29	15.61	19.35	26.72	11.50
PE Ratio	-	-15.38	-6.94	-5.78	-11.00	-0.07
PB Ratio	4.10	4.66	6.82	6.99	8.17	-2.74
P/TBV Ratio	3.91	4.05	6.56	6.69	5.16	-0.04
P/FCF Ratio	-	-19.82	-7.52	-7.95	-23.98	-7.01
P/OCF Ratio	-	-19.96	-7.53	-7.96	-23.98	-7.03
EV/EBITDA Ratio	-	-12.73	-5.86	-5.05	-14.43	-6.36
EV/EBIT Ratio	-	-12.56	-5.73	-4.97	-14.35	-6.33
EV/FCF Ratio	-	-15.48	-6.34	-6.68	-20.83	-9.47
Debt / Equity Ratio	0.16	0.09	0.50	0.37	0.07	0
Debt / EBITDA Ratio	-0.33	-0.33	-0.54	-0.35	-0.14	-
Debt / FCF Ratio	-0.42	-0.40	-0.58	-0.46	-0.21	-
Quick Ratio	16.59	25.26	7.21	4.48	10.36	22.30
Current Ratio	17.03	25.67	7.71	4.91	10.73	22.55
Return on Equity (ROE)	-41.76%	-44.83%	-107.50%	-121.58%	-54.43%	-106.34%
Return on Assets (ROA)	-38.25%	-40.22%	-66.46%	-84.49%	-49.75%	-95.76%
Return on Capital (ROIC)	-3378.18%	-2808.42%	-1422.68%	-1823.55%	-2420.19%	-4162.71%
Return on Capital Employed (ROCE)	-40.17%	-42.67%	-78.75%	-99.95%	-53.67%	-100.18%
Earnings Yield	-11.37%	-6.50%	-14.41%	-17.31%	-9.09%	-1451.57%
FCF Yield	-9.71%	-5.05%	-13.29%	-12.58%	-4.17%	-14.27%
Buyback Yield / Dilution	-0.34%	-24.03%	-16.73%	-16.40%	-9.10%	-0.09%
Total Shareholder Return	-	-24.03%	-16.73%	-16.40%	-9.10%	-0.09%

Updated Aug 5, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q